Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume $7.32 -0.26 (-3.43%) (As of 11/13/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals Short Interest DataRecursion Pharmaceuticals (RXRX) has a short interest of 62.43 million shares, representing 27.97% of the float (the number of shares available for trading by the public). This marks a 5.03% increase in short interest from the previous month. The short interest ratio (days to cover) is 12.7, indicating that it would take 12.7 days of the average trading volume of 5.73 million shares to cover all short positions.Current Short Interest62,430,000 sharesPrevious Short Interest59,440,000 sharesChange Vs. Previous Month+5.03%Dollar Volume Sold Short$394.56 millionShort Interest Ratio12.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares281,110,000 sharesFloat Size223,170,000 sharesShort Percent of Float27.97%Today's Trading Volume6,581,078 sharesAverage Trading Volume5,726,985 sharesToday's Volume Vs. Average115% Short Selling Recursion Pharmaceuticals? Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRXRX Short Interest Over TimeRXRX Days to Cover Over TimeRXRX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Recursion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202462,430,000 shares $394.56 million +5.0%28.0%12.7 $6.32 10/15/202459,440,000 shares $396.46 million -5.0%26.2%12.2 $6.67 9/30/202462,580,000 shares $412.40 million +5.8%27.9%12.3 $6.59 9/15/202459,160,000 shares $388.68 million +5.6%26.5%10.2 $6.57 8/31/202456,030,000 shares $407.90 million +3.5%26.0%9.9 $7.28 8/15/202454,150,000 shares $362.26 million +7.5%25.1%9.6 $6.69 Get the Latest News and Ratings for RXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202450,370,000 shares $413.03 million +2.1%24.7%8.8 $8.20 7/15/202449,330,000 shares $404.51 million +9.8%24.8%8.9 $8.20 6/30/202444,920,000 shares $336.90 million 0.0%23.6%8.5 $7.50 6/15/202444,930,000 shares $416.05 million +3.0%26.5%9.6 $9.26 5/31/202443,640,000 shares $361.34 million +3.0%26.7%8.6 $8.28 5/15/202442,370,000 shares $424.12 million +4.6%26.1%7.3 $10.01 4/30/202440,500,000 shares $316.71 million +4.7%25.0%6.5 $7.82 4/15/202438,700,000 shares $301.47 million -2.7%26.4%6.2 $7.79 3/31/202439,760,000 shares $396.41 million -8.6%27.1%5.7 $9.97 3/15/202443,520,000 shares $488.29 million +1.6%29.7%6.2 $11.22 2/29/202442,820,000 shares $576.36 million +12.0%29.2%6.4 $13.46 2/15/202438,240,000 shares $475.32 million -0.1%26.1%6 $12.43 1/31/202438,270,000 shares $360.12 million +0.5%25.2%7.1 $9.41 1/15/202438,090,000 shares $425.08 million +2.8%25.1%7.3 $11.16 12/31/202337,040,000 shares $365.21 million +0.1%24.4%8.1 $9.86 12/15/202337,020,000 shares $359.09 million +3.1%24.4%9.2 $9.70 11/30/202335,920,000 shares $246.05 million +1.2%23.9%9.1 $6.85 11/15/202335,500,000 shares $254.89 million +7.4%23.6%9.6 $7.18 10/31/202333,050,000 shares $174.50 million +3.8%23.9%9.3 $5.28 10/15/202331,850,000 shares $203.20 million +3.6%23.0%8.5 $6.38 9/30/202330,750,000 shares $235.24 million +26.3%22.2%4.6 $7.65 9/15/202324,340,000 shares $208.59 million +5.6%17.7%3.8 $8.57 8/31/202323,040,000 shares $200.45 million +11.8%17.6%3.8 $8.70 8/15/202320,610,000 shares $189.41 million +4.8%15.8%3.3 $9.19 7/31/202319,670,000 shares $277.74 million -0.3%16.6%3.4 $14.12 7/15/202319,720,000 shares $234.67 million +6.4%16.7%3.8 $11.90 6/30/202318,540,000 shares $138.49 million -5.0%15.7%8.9 $7.47 6/15/202319,520,000 shares $181.54 million +5.7%16.5%9.7 $9.30 5/31/202318,460,000 shares $161.89 million -7.7%15.8%9.9 $8.77 5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60 4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77 4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94 3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67 3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48This “IRS Loophole” Allows You to Do WHAT? (Ad)Little-Known IRS Loophole Beats Inflation 4x Over New guide reveals how to take advantage of this federally-approved process. [RUSH MY FREE GUIDE NOW] 2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15 2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44 1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33 1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70 12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71 12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47 11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40 11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86 10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55 10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49 9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64 9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11 8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51 8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96 7/31/202216,770,000 shares $141.87 million +4.9%20.2%16.6 $8.46 7/15/202215,990,000 shares $135.92 million +11.7%19.3%15.4 $8.50 6/30/202214,310,000 shares $116.48 million +3.0%17.3%13 $8.14 6/15/202213,890,000 shares $92.79 million -0.9%16.7%12.9 $6.68 5/31/202214,020,000 shares $85.80 million +3.4%17.1%12.5 $6.12 5/15/202213,560,000 shares $76.48 million -3.0%16.5%11.3 $5.64 4/30/202213,980,000 shares $86.68 million +0.4%17.1%12.1 $6.20 4/15/202213,920,000 shares $103.84 million -5.6%17.2%11.9 $7.46 3/31/202214,740,000 shares $105.54 million -8.2%16.9%12.7 $7.16 3/15/202216,060,000 shares $100.38 million -1.6%18.7%13.3 $6.25 2/28/202216,320,000 shares $178.70 million +5.0%19.0%11.1 $10.95 2/15/202215,550,000 shares $185.05 million +6.4%17.9%10.4 $11.90 1/31/202214,620,000 shares $173.10 million +5.6%16.7%9.3 $11.84 1/15/202213,840,000 shares $191.13 million +3.3%15.8%8.7 $13.81 12/31/202113,400,000 shares $229.54 million +20.8%15.3%8.5 $17.13 12/15/202111,090,000 shares $219.03 million +4.0%12.6%7.3 $19.75 11/30/202110,660,000 shares $203.82 million -2.8%12.8%9.4 $19.12 11/15/202110,970,000 shares $205.69 million -5.5%13.2%12 $18.75 10/29/202111,610,000 shares $222.33 million -10.8%14.0%15.7 $19.15 10/15/202113,010,000 shares $247.71 million +8.5%15.7%21.3 $19.04 9/30/202111,990,000 shares $275.89 million +31.9%14.5%24.4 $23.01 9/15/20219,090,000 shares $217.71 million +25.2%12.0%18.9 $23.95 8/31/20217,260,000 shares $183.10 million +19.0%9.6%16.5 $25.22 8/13/20216,100,000 shares $137.07 million No Change7.6%15.2 $22.47 RXRX Short Interest - Frequently Asked Questions What is Recursion Pharmaceuticals' current short interest? Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 62,430,000 shares of RXRX short. 27.97% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest. What is a good short interest ratio for Recursion Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 13.0. Learn More on Recursion Pharmaceuticals's short interest ratio. Which institutional investors are shorting Recursion Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Recursion Pharmaceuticals: Sculptor Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Recursion Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 27.97% of Recursion Pharmaceuticals' floating shares are currently sold short. Is Recursion Pharmaceuticals' short interest increasing or decreasing? Recursion Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 62,430,000 shares, an increase of 5.0% from the previous total of 59,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Recursion Pharmaceuticals' float size? Recursion Pharmaceuticals currently has issued a total of 281,110,000 shares. Some of Recursion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recursion Pharmaceuticals currently has a public float of 223,170,000 shares. How does Recursion Pharmaceuticals' short interest compare to its competitors? 27.97% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Recursion Pharmaceuticals: SpringWorks Therapeutics, Inc. (15.66%), Arcus Biosciences, Inc. (13.82%), Schrödinger, Inc. (12.23%), AbCellera Biologics Inc. (8.04%), Relay Therapeutics, Inc. (8.99%), Exscientia plc (2.55%), Emergent BioSolutions Inc. (13.35%), Absci Co. (13.94%), Viking Therapeutics, Inc. (11.92%), Elanco Animal Health Incorporated (2.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Recursion Pharmaceuticals stock? Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Recursion Pharmaceuticals? A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further. How often is Recursion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies SWTX Short Interest SDGR Short Interest RCUS Short Interest ABCL Short Interest RLAY Short Interest EXAI Short Interest EBS Short Interest ABSI Short Interest ASND Short Interest LEGN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RXRX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThis “IRS Loophole” Allows You to Do WHAT?Little-Known IRS Loophole Beats Inflation 4x Over New guide reveals how to take advantage of this federally...Gold Safe Exchange | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.